{"name":"Xiao-Ming Mao","slug":"xiao-ming-mao","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"MMI","genericName":"MMI","slug":"mmi","indication":"Parkinson's disease","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"MMI combined with IID","genericName":"MMI combined with IID","slug":"mmi-combined-with-iid","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"MMI","genericName":"MMI","slug":"mmi","phase":"marketed","mechanism":"MMI is a selective monoamine oxidase B (MAO-B) inhibitor.","indications":["Parkinson's disease"],"catalyst":""},{"name":"MMI combined with IID","genericName":"MMI combined with IID","slug":"mmi-combined-with-iid","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPaDFGTG84NV95OFg5YWV2XzdmSVhzVjBFUkRIcWtKSHZzajhaUjVnMzNKRHBmQ0VjSjRJcFFYeHctVm1tZ0RZc2dQU3cycG55dW1yZVE3OFlQTWRRa25la0dDbjJyZnl6SWtXdGktMWoySmpCWlhLRHBTU214dGVpeG9qTVZ0SFRaYThqMTlTZm4yR3poVkdqVFcxbzJhcmkyaUVURDNiWHJGNk9BU0VGUVhwd28xTU5wRVFneGE5X1I?oc=5","date":"2024-11-22","type":"earnings","source":"saltwire.com","summary":"Processor accused of profiting off illegal lobster, elver fisheries in N.S. - saltwire.com","headline":"Processor accused of profiting off illegal lobster, elver fisheries in N.S.","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}